Free Trial

CollPlant Biotechnologies (CLGN) Earnings Date, Estimates & Call Transcripts

CollPlant Biotechnologies logo
$4.23 +0.04 (+0.95%)
(As of 11/20/2024 ET)

CollPlant Biotechnologies Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 27Before Market OpensConfirmed
Actual EPS
(Aug. 20)
-$0.37 Missed By -$0.02
Consensus EPS
(Aug. 20)
-$0.35

CollPlant Biotechnologies released Q2 2024 earnings on August 20, 2024, reporting an EPS of -$0.37, which missed analysts' consensus estimates of -$0.35 by $0.02. Quarterly revenue was reported to be $0.25 million, below the consensus estimate of $0.70 million. With a trailing EPS of -$1.54, CollPlant Biotechnologies' earnings are expected to grow next year, from ($1.44) to ($0.56) per share.

CLGN Upcoming Earnings

CollPlant Biotechnologies' next earnings date is scheduled for Wednesday, November 27, 2024, with a conference call scheduled for at 10:00 AM ET. Interested parties can register for or listen to the call.

Get CollPlant Biotechnologies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CollPlant Biotechnologies and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CLGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CollPlant Biotechnologies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241-$0.37-$0.37-$0.37
20241-$0.37-$0.37-$0.37
Q1 20251-$0.37-$0.37-$0.37
Q2 20251$0.29$0.29$0.29
Q3 20251-$0.31-$0.31-$0.31
Q4 20251-$0.31-$0.31-$0.31
FY 20254($0.70)($0.70)($0.70)

CollPlant Biotechnologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/27/2024
(Confirmed)
-------  
8/20/2024Q2 2024-$0.35-$0.37 -$0.02-$0.37$0.70M$0.25M
5/29/2024Q1 2024-$0.35-$0.37 -$0.02-$0.37$0.60M$0.10M  
4/4/2024Q4 2023--$0.42 -$0.42-$0.42-$0.30M
11/29/2023Q3 2023-$0.02-$0.38 -$0.36-$0.38$5.12M$0.04M  
8/24/2023Q2 2023-$0.34$0.49+$0.83$0.49$0.26M$10.18M      
5/24/2023Q1 2023-$0.29-$0.33 -$0.04-$0.33$0.24M$0.43M  
3/29/2023Q4 2022-$0.21-$0.39 -$0.18-$0.39-$0.06M  
12/1/2022Q3 2022-$0.31-$0.40 -$0.09-$0.40-$0.11M  

CollPlant Biotechnologies Earnings - Frequently Asked Questions

CollPlant Biotechnologies has confirmed that its next quarterly earnings data will be published on Wednesday, November 27th, 2024. Learn more on CLGN's earnings history.

In the previous quarter, CollPlant Biotechnologies (NASDAQ:CLGN) missed the analysts' consensus estimate of ($0.35) by $0.02 with a reported earnings per share (EPS) of ($0.37). Learn more on analysts' earnings estimate vs. CLGN's actual earnings.

CollPlant Biotechnologies (NASDAQ:CLGN) has a recorded annual revenue of $10.96 million.

CollPlant Biotechnologies (NASDAQ:CLGN) has a recorded net income of -$7.02 million. CLGN has generated -$1.54 earnings per share over the last four quarters.

CollPlant Biotechnologies's earnings are expected to grow from ($1.44) per share to ($0.56) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CLGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners